What is the relationship between Beijing Medicine and China Medicine?

China Pharmaceutical Group Co., Ltd., namely China Pharmaceutical Group, is the largest pharmaceutical and health industry group in China directly managed by the state, with the most complete industrial chain and the strongest comprehensive strength. It focuses on distribution, retail, research and development and production of health-related products, such as preventive treatment and diagnostic care. It has more than 65,438+0,500 subsidiaries, and six listed companies, including Sinopharm Holdings, Sinopharm Shares, Sinopharm Consistent, Tiantan Bio, Hyundai Pharmaceutical and China Traditional Chinese Medicine.

Beijing Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Beijing Pharmaceutical Group") is a large state-owned comprehensive pharmaceutical industry group with diversified shares. Founded in 1979, formerly known as Beijing Pharmaceutical Corporation. The total assets of the group are 654.38+05.622 billion yuan, and there are more than 24,000 employees. There are two divisions, namely Natural Medicine Division and Prescription Medicine Division, which hold shares in more than 20 companies, including Shuanghe Pharmaceutical and 1 listed companies. In 2009, Beijing Pharmaceutical Group achieved sales revenue of nearly 27 billion yuan, net profit of more than 400 million yuan, and the overall return on net assets of the group reached 12%, ranking among the top pharmaceutical enterprises in China in comprehensive strength.